Effects of Combination of Aidi Injection and Neoadjuvant Chemotherapy on Patients with Non-Small-Cell Lung Cancer and Number of CD4CD25 T Regulatory Cells

TENG Yin; XIAO Jia-rong; LIN Peng; ZHANG Jian

您当前的位置：

首页 >

文章列表页 >

Effects of Combination of Aidi Injection and Neoadjuvant Chemotherapy on Patients with Non-Small-Cell Lung Cancer and Number of CD4CD25 T Regulatory Cells

更新时间：2024-09-23

- Effects of Combination of Aidi Injection and Neoadjuvant Chemotherapy on Patients with Non-Small-Cell Lung Cancer and Number of CD4CD25 T Regulatory Cells
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 18, Issue 18, Pages: 291-294(2012)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC：
- Published：2012
- 稿件说明：
移动端阅览
TENG Yin, XIAO Jia-rong, LIN Peng, et al. Effects of Combination of Aidi Injection and Neoadjuvant Chemotherapy on Patients with Non-Small-Cell Lung Cancer and Number of CD4CD25 T Regulatory Cells[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(18): 291-294.
DOI：

TENG Yin, XIAO Jia-rong, LIN Peng, et al. Effects of Combination of Aidi Injection and Neoadjuvant Chemotherapy on Patients with Non-Small-Cell Lung Cancer and Number of CD4CD25 T Regulatory Cells[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(18): 291-294. DOI：

摘要

目的: 探讨术前艾迪注射液联合新辅助化疗用于治疗非小细胞肺癌(NSCLC)的疗效。方法: 选取NSCLC患者55例

根据在新辅助化疗时是否联合使用艾迪注射液分为对照组与治疗组

对照组未使用艾迪注射液

共20例

治疗组使用艾迪注射液

共35例。观察两组患者近期疗效、手术时间、出血量、切除率以及毒副反应

并通过流式细胞术检测治疗前后患者外周血CD4+CD25+调节性T细胞数量。结果: 与对照组相比

治疗组患者手术出血量显著下降(P<0.05)

分别为(615.49±114.08)mL与(530.15±104.55)mL;治疗总有效率显著上升(P<0.05)

分别为30.00%

45.71%;白细胞减少发生率显著下降(P<0.05)

分别为60.00%

37.14%;与治疗前相比

所有患者外周血CD4+CD25+调节性T细胞显著降低(P<0.05)

以治疗组患者降低更加明显(P<0.05)。结论: 艾迪注射液联合新辅助化疗可提高NSCLC的治疗效果

提高肿瘤免疫

减少不良反应。

Abstract

Objective: To explore effect of combination of Aidi injection and neoadjuvant chemotherapy on patients with non-small-cell lung cancer and number of CD4+CD25+ T regulatory cells (NSCLC). Method: Fifty patients with NSCLC were chosen for this research. Patients were divided into control group of 20 patients without application of Aidi injection and treatment group of 35 patients applied with Aidi injection. The following indexes like their short-term curative effect

operation time

blood loss in operations

ablation rate and side effects were observed;flow cytometry was used to detect and compare number of Treg before and after treatments. Result: Compared with control group

blood loss in operation was decreased significantly (615.49±114.08)mL vs.(530.15±104.55)mL (P<0.05)

curative effect increased significantly (30.00% vs 45.71%) (P<0.05)

and occurrence of leucopenia decreased significantly (60.00% vs 37.14%) (P<0.05). Number of Treg was decreased significantly after treatments for all patients (P<0.05)

which was more significant in treatment group than in control group (P<0.05). Conclusion: Combination of Aidi injection and neoadjuvant chemotherapy can enhance clinical effects on patients with NSCLC

meanwhile enhance tumor immunity and reduce side effect during the treatment.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effects of Combination of Aidi Injection and Neoadjuvant Chemotherapy on Patients with Non-Small-Cell Lung Cancer and Number of CD4⁺CD25⁺ T Regulatory Cells

Regulation of Tumor Immune Homeostasis by Programmed Cell Death and Intervention Effect of Traditional Chinese Medicine Under Theory of Regulating Qi and Resolving Toxins

Shuyuwan Regulates M1/M2 Polarization of Tumor-associated Macrophages to Inhibit Progression of Colorectal Cancer

Effect of Modified Bazhentang on Nutritional Status and Immune Function of Gastric Cancer Patients with Neoadjuvant Chemotherapy

Effect of Aidi Injection on Expression of Cytochrome P450 Enzyme in DEN-induced Hepatocellular Carcinoma Rats

Related Author

ZHANG Jian

LIN Peng

XIAO Jia-rong

TENG Yin

HUA Baojin

LI Weidong

ZHAI Haoyu

WANG Chenglei

Related Institution

Department of Thoracic Surgery,Affiliated Hospital of Guiyang Medical College

Guang'anmen Hospital， China Academy of Chinese Medical Sciences

Graduate School， Shaanxi University of Chinese Medicine

Affiliated Hospital of Jiangxi University of Chinese Medicine

Affiliated Hospital of Chengde Medical University

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰